Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 3.550
-0.095 (-2.61%)
Sep 18, 2026, 4:00 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 53.48 million as of September 18, 2026. Its market cap has decreased by -45.41% in one year.
Market Cap
53.48M
Enterprise Value
52.74M
Revenue
30.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.55
ChartMarket Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 53.48M, a decrease of -51.62%. That is a compound annual growth rate of -12.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 53.48M | -6.58% |
| Dec 30, 2025 | 57.25M | -45.34% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synektik Spólka Akcyjna | 2.94B |
| Medinice | 662.63M |
| Medicalgorithmics | 253.80M |
| Milton Essex Spólka Akcyjna | 40.94M |
| Nestmedic | 29.88M |
| InventionMed | 22.31M |
| Adiuvo Investments | 9.01M |
| Zortrax | 1.18M |